INTERNATIONAL PATENT: CUREVAC SE, THE SCHEPENS EYE RESEARCH INSTITUTE, INC. FILES APPLICATION FOR "NUCLEIC ACID ENCODED RUNX3 TRANSCRIPTION FACTOR"

GENEVA, Feb. 10 -- CUREVAC SE (Friedrich-Miescher-StraBe 1572076 Tubingen), THE SCHEPENS EYE RESEARCH INSTITUTE, INC. (20 Staniford StreetBoston, Massachusetts 02114) filed a patent application (PCT/EP2024/071649) for "NUCLEIC ACID ENCODED RUNX3 TRANSCRIPTION FACTOR" on Jul 31, 2024. With publication no. WO/2025/027060, the details related to the patent application was published on Feb 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): REJMAN, Joanna (c/o CureVac SEFriedrich-Miescher-StraBe 1572076 Tubingen), ARBOLEDA-VELASQUEZ, Joseph (35 Lodge RoadNewton, MA 02465), KIM, Leo A. (302 Mason...